NICOTINAMIDE, a form of vitamin B3 also known as niacinamide, may help prevent skin cancer, according to US research into the over-the-counter supplement.

The study involved over 33,000 people, of whom around 12,000 took 500mg twice daily for over 30 years.

Compared to those who did not take the supplement, those who took nicotinamide had the risk of skin cancer reduced by 14% – and by 54% among those who had already had one skin cancer.

A/Prof Yousuf Mohammed, from the School of Pharmacy and Pharmaceutical Sciences at the University of Queensland, commented that the study suggested nicotinamide is an “underutilised, low-risk intervention that can make a difference in reducing skin cancer burden, especially for patients with an early history of disease” – read the study HERE.

The post B3 skin cancer role appeared first on Pharmacy Daily.